Recombinant interleukin-12
Term · Oncology and biomedicine · MLC-T-ONC-016435
A recombinant form of the endogenous heterodimeric cytokine interleukin-12 with potential antineoplastic activity. Recombinant interleukin-12 binds to and activates its cell-surface receptor, stimulating the production of interferon-gamma (IFN) which, in turn, induces IFN-gamma-inducible protein-10 (IP-10) and so inhibits tumor angiogenesis.
| Identifier | MLC-T-ONC-016435 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | IL-12 |
| Synonyms | NM-IL-12; interleukin-12; cytotoxic lymphocyte maturation factor; natural killer cell stimulatory factor; recombinant human interleukin-12 (IL-12) cytokine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016435",
"term": "Recombinant interleukin-12",
"field": "Oncology and biomedicine",
"definition": "A recombinant form of the endogenous heterodimeric cytokine interleukin-12 with potential antineoplastic activity. Recombinant interleukin-12 binds to and activates its cell-surface receptor, stimulating the production of interferon-gamma (IFN) which, in turn, induces IFN-gamma-inducible protein-10 (IP-10) and so inhibits tumor angiogenesis.",
"abbreviation": "IL-12",
"synonyms": [
"NM-IL-12",
"interleukin-12",
"cytotoxic lymphocyte maturation factor",
"natural killer cell stimulatory factor",
"recombinant human interleukin-12 (IL-12) cytokine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-interleukin-12/"
}
Record 14,181 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.